Oral tolerance induction by type V collagen downregulates lung allograft rejection

American Journal of Respiratory Cell and Molecular Biology

Volumn 25, Issue 1, 2001, Pages 26-34

  Yasufuku, K ^a   Heidler, K M ^a   O'Donnell, P W ^a   Smith G N , Jr ^a   Cummings, O W ^a   Foresman, B H ^a   Fujisawa, T ^a   Wilkes, D S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0034921485     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.25.1.4431     Document Type: Article

References (35)

1. Lung transplantation
2. Mechanism of T cell recognition of alloantigen
3. De nuvo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process
4. Oral tolerance: Mechanisms and therapeutic applications
5. Novel immunotherapeutic strategies using MHC derived peptides
6. HLA-derived peptides as novel immunosuppressives
7. Induction of transplantation tolerance to rat cardiac allografts by intrathymic inoculation of allogeneic soluble peptides
8. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen
9. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes
10. Oral tolerance: New approaches, new problems
11. Type V collagen modulates alloantigen-induced pathology and immunology in the lung
12. Interaction of proteoglycans with pericellular (1 alpha, 2 alpha, 3 alpha) collagens of cartilage
13. Type XI collagen is a heterotrimer with the composition (1α, 2α, 3α) retaining non-triple helical domains
14. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen
15. Role of passenger leukocytes in allograft rejection - Effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation
16. Lung transplantation in the rat. III. Functional studies in iso- and allografts
17. Lung allograft rejection in the rat: I. Accelerated rejection caused by graft lymphocytes
18. Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation
19. Suppression of allograft rejection with anti-alpha beta T cell receptor antibody in rat corneal transplantation
20. A sensitive delayed-type hypersensitivity model in the rat for assessing in vivo cell-mediated immunity
21. Transforming growth factor-beta and interteukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice
22. In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury
23. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group
24. Patterns of allosensitization in allograft recipients: Long-term allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity
25. Immune mechanisms in organ allograft rejection: VI. Delayed-type hypersensitivity and lymphotoxin in experimental renal allograft rejection
26. Comparison of mononuclear cell populations in bronchoalveolar lavage fluid in acute rejection after lung transplantation and Mycoplasma infection in rats
27. Dietary salt modulates renal production of transforming growth factor-beta in rats
28. Collagen polymorphism in the lung
29. Isolation and tissue localization of type AB2 collagen from normal lung parenchyma
30. Localization of type V collagen and type IV collagen in human cornea, lung, and skin
31. Allogeneic bronchoalveolar lavage cells induce the histology of acute lung allograft rejection, and deposition of IGg2a in recipient murine lungs
32. Regulatory T-cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
33. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment
34. Stable chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model
35. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells